Resources

Long-term Outcomes of Lentiviral Gene Therapy for the β-hemoglobinopathies: the HGB-205 Trial

Subscribe to Our Email List

Talk to Our Experts

Whether you are looking to learn more about our platforms or get a project started, contact our team today to discover how ProtaGene can support your development programs.